Experic Announces Growth Capital Investment Led by 1315 Capital
10/29/24, 10:38 AM
Location
Industry
manufacturing
biotechnology
health care
Type
partnership
Experic, a US-based contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the global biopharmaceutical industry, has announced a significant growth capital investment led by 1315 Capital, a Philadelphia-based, growth equity firm focused on healthcare.
Company Info
Location
cranbury, new jersey, united states
Additional Info
Experic, a contract development and manufacturing organization (CDMO) and pharmaceutical supply services company, supports every phase of a product’s life cycle from conception to clinical and commercial scale, across a range of dosing and packaging formats, including tablets, pellets, capsules, and low dose dry powder inhalation. From our state-of-the-art, Class A cGMP facility, we manage global delivery of the highest quality products, even for expedited projects, while providing unparalleled knowledge, expertise, and customer service.